Be used to spur economic recovery but first remind folks what the Tax Foundation does and how you do it. The Tax Foundation is an organization that educates the public on tax policy and also assist members of congress in developing tax policy. We do in particular analysis of the cost to the economy and to the government of tax increases or tax decreases, Tax Foundation. Org is a website as. As we look at recovery efforts, its now been four months since america startedon shutting down. Congress congress is appropriatr 2. 5 trillion in response. At what point do we start focusing on longterm recovery as opposed to responding to immediate needs that are happening in the here and now . Guest thats hard to say. I had originally thought when the crisis began that around the end of the summer we would need to make a strong tilt towards longterm growth. We had sort of a threepart approach to this during the immediate crisis we needed to write liquidity for businesses, for households so they co
It started it. It essentially was the industry which was unpacking the biology of cells and understanding how those biology cells could be used to make new medicines, a little different from what pharma was an pharma in the past was essentially trying out medicines on animals and seeing if they work and then put them into a human being a Clinical Trial process once we understood how the genes work, once we knew how to manipulate those jeans, a whole new ability to transform what we knew about cells into medicines came into being. This was areal revolution , and about in the 70s and walked through to the 80s and then now today there are approximately a couple thousand companies, about 700 of whom are members of bio, many are private. They are now much smaller industries in the europe and in asia and actually, these Small Companies although they are tiny and they represent no more than any one of the Big Companies in terms of numbers, theyre generating about 70 70 percent of all the medi
Levin is the chairman of the innovation organization. It encompasses the tech industry. Biotech industry was mutilated, unpacking the biology of cells and understanding how the biology of those cells make new mentions. A little different than pharma was, on animals and see if they worked and put them into a human being through a clinical trial, once we understood how to manipulate the genes, a new ability to know about cells until medicine came into being. And now today there are approximately 700 members, privates much smaller industries in europe and asia and actually companies that are tiny and represent no more than the Big Companies in terms of numbers employed generating 70 of all the medicine. What is the difference . Real simple. In the biotechnology industry there is an absolute focus on patient and innovation, new ways of delivering medicine. It is the stocks of these companies. It is a different structure. Insurance companies are huge, they are very substantial. The way they
Chair discusses the coronavirus. Join the conversation on facebook and twitter. Washington host good morning. It is monday, july 13, 2020. A threehour washington journal ahead and we begin the day the race from the for the white house and we are three weeks away from Vice President joe biden announcing his running mate. We want to hear from democrats who do you think joe biden should pick to be on the 2020 ticket . Democrats in the eastern or central time zones can call in o 274 88000. You can also send us a text. Please include your name and where you are from. A good monday morning. As a reminder, joe biden has said he would pick a woman to be his running mate in 2020, so that helps narrow down the list, but were asking democrats who runninge joe bidens mate. This piece takes up the 11 most logical picks. The top three, congresswoman val demings of florida, senator Elizabeth Warren of massachusetts, and the number one pick, senator, harris of california. Aaron blake writes she has be
The biotech industry was formulated in the united states. It was an industry that was unpacking the biology of cells, understanding how the biology of these cells could be used to made new medicine to make new medicines. Pharma in the past was essentially trying out medicines on animals to see if they worked and then put them into a human being through a Clinical Trial process. Once we understood how the genes worked, how to manipulate those genes, a whole new ability to transform what we knew about cells into medicine came into being. This is a real revolution. It started in the 1970s, walked through the 1980s and now today. There are approximately a couple thousand companies, about 700 of whom are members of bio. Many others are private. There are smaller industries in and these in asia small companies, although tiny represent no more than anyone of the Big Companies in terms of numbers of employees, generating about 70 of all medicine. What is the difference . It is simple. In the b